Viridian Therapeutics, Inc.\DE (VRDN) Accumulated Depreciation & Amortization (2016 - 2025)
Viridian Therapeutics, Inc.\DE (VRDN) has 12 years of Accumulated Depreciation & Amortization data on record, last reported at $500000.0 in Q4 2025.
- For Q4 2025, Accumulated Depreciation & Amortization changed 0.0% year-over-year to $500000.0; the TTM value through Dec 2025 reached $500000.0, changed 0.0%, while the annual FY2025 figure was $500000.0, 0.0% changed from the prior year.
- Accumulated Depreciation & Amortization reached $500000.0 in Q4 2025 per VRDN's latest filing, roughly flat from $500000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $500000.0 in Q4 2023 and bottomed at $30000.0 in Q3 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $247000.0, with a median of $177500.0 recorded in 2021.
- Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 56.06% in 2021, then soared 155.0% in 2022.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $100000.0 in 2021, then skyrocketed by 155.0% to $255000.0 in 2022, then soared by 96.08% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $500000.0 in Q4 2025, $500000.0 in Q4 2024, and $500000.0 in Q4 2023.